Rituximab intralesional como tratamiento de linfoma folicular primario de conjuntiva recidivante

Intralesional administration of rituximab for treating primary FL of the conjunctiva was an effective and safe therapeutic option; therefore it could be an alternative to other conventional treatments, such as radiotherapy or chemotherapy.